News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eisai Company, Ltd. (ESALY.PK)'s Cancer Drug Reverses Alzheimer's Symptoms


2/10/2012 7:08:30 AM

In what is seen as a major breakthrough in finding a cure for Alzheimer's, neuroscientists at Case Western Reserve University School of Medicine, Ohio, have found that the use of a cancer drug quickly reversed Alzheimer's symptoms in mice in a study. The drug - Bexarotene, marketed in the United States by Eisai Inc. under the brand name Targretin, is already approved by the FDA for the treatment of cutaneous T-cell lymphoma, or CTCL skin cancer. Alzheimer's disease is characterized by a buildup of toxic amyloid beta peptide and amyloid plaques, which causes changes or deterioration in certain areas of the brain that control thinking, communication, and behavior.

Read at Nasdaq
Read at Bloomberg
Read at Wall Street Journal
Read at AFP
Read at Fox News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES